ASIA MEETING: INTERVENTIONS FOR IMPACT IN EONC DAY 1 8:30
110 Min 20 min 15 min
4 May 2012 Improvements in MH: The Changing Situation of MH Maternal Mortality 1990-2011 Reductions in Maternal Mortality – Bangladesh
Det ails
Chair: Sir Arul OR Nahed OR Regional Director UNFPA/WHO H4 Representative – WHO (Metin or other WHO), World Bank (?) OR UNFPA (Luc de Bernis) Bangladesh Govt. – MoH or MH Champion
(key elements of country experience including TFR reduction)
15 min
Reductions in Maternal Mortality – Afghanistan
Afghanistan Govt. - MoH or MH Champion
(key elements of country experience including Health HR development and community interventions)
15 min 15 min
Reductions in Maternal Mortality – Nepal
Nepal Govt. – MoH or MH Champion
Reductions in Maternal Mortality – Cambodia
Cambodia Govt. – MoH or MH Champion
(key elements of country experience including community interventions and PAC) (key elements of country experience including increasing SBA and financing – midwife incentives/equity funds)
10:20
30 min
DISCUSSION
30 Min
TEA
100 Min TOTAL
Global Evidence and Guidance for PPH Prevention and Treatment
15 min
WHO PPH Guidance, with some reference to Task Shifting: WHO AMTSL Trial
15 min 15 min 15 min 35 min 12:30
90 Min
14:00
75 Min TOTAL
Chair to summarize themes at start of discussion
Position Statements of FIGO and Role of Prof Associations Prevention and Management Strategies at different levels of health system DISCUSSION
15 min 15:15
30 Min
Afternoon TEA Break
15:45
75 Min TOTAL 15 min 15 min
Drugs and Commodities
15 min 15 min 15 min
Improving the quality of uteronics The horizons of oxytocin- TTIs, Heat Stable Oxytocin DISCUSSION
15 min
Wrap –Up Day One
10 min 15 min 12 min 12 min
17:00
WHO – Metin Gulmezoglu, Justus Hofmeyr, Shiva Goudar or Debbie Armbruster FIGO – Sir Sabaratnam Arulkumaran (Arul) or his designate USAID - Debbie Armbruster OR someone from Asia?. Pisake Limbagayone from Thailand?
LUNCH (Problem Solving discussion round tables/Task force meetings) Overcoming barriers and measuring success: Implementing PPH prevention and management programs Global overview of PPH Scale up: A Multi-country Analysis Maternal Health Indicators and Use of a Uterotonic in 3rd stage Experience with community level use of misoprostol in Asia Implementation experience: Bangladesh highlighting operational issues. Implementation experience: Nepal highlighting national scale up. DISCUSSION
10 min
Chair: Regional WHO or UNFPA Head of MH – Saramma Mathai, WHO Regional MH advisor OR Vincent Faveau (?) WHO – Metin Gulmezoglu or Matthews Mathai
Quality of Oxytocin and Ergometrine, India Quality of misoprostol
Chair: Koki OR Ann Starrs or Alice MCHIP – Jeffrey Smith MCHIP- Steve Hodgins VSI- Ndola Prata or designate Bangladesh- names TBD Nepal- names TBD
Chair: USAID - Maria Moralles OR Catharine Taylor or Alice Oxytocin Initiative- Cindy Stanton (JHU) Gynuity/Concept Foundation- Beverly Winikoff and Peter Hall USP – Patrick Lukulay or designate Hans Hogerzeil
Alice or Jeff